Ignite Creation Date:
2024-05-06 @ 8:17 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06321094
Status:
RECRUITING
Last Update Posted:
2024-03-20
First Post:
2024-03-06
Brief Title:
Effect of Vericiguat on Endpoint Events in Acute Coronary Syndrome ACSPatients With Ejection Fraction 45
Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Organization:
The First Affiliated Hospital with Nanjing Medical University
Study Overview
Official Title:
Effect of Vericiguat on Endpoint Events in ACS Patients With Ejection Fraction 45a Prospective Preventional Clinical Study
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Investigators evaluate whether differences exsit in acute coronary syndromeACS patients with ejection 45 between participants who take vericiguat regularly and those who donot
Detailed Description:
Vericiguat a novel soluble guanylate cyclase stimulator reduced the incidence of cardiovascular death or hospitalization for HF in a population of high-risk patients with heart failure with reduced ejection fraction HFrEF who had recently been hospitalized or received intravenous diuretic therapyGiven the increasing incidence of patients with ACS and its challenges posing to lifeinvestigators intend to conduct a prospective observational study Investigators choose several meaningful endpoints including the time of cardiovascular death or heart failureHF hospitalizationinflammatory markersthe value of N-terminal pro-B-type natriuretic peptideNT-proBNPresults of echocardiogram and life quality scoreBy collecting these datas and work on a group of analysis investigators evaluate whether differences exsit in ACS patients with ejection 45 between participants who take vericiguat regularly and those who donot
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None